17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial

BMC Research Notes ◽

10.1186/1756-0500-4-568 ◽

2011 ◽

Vol 4 (1) ◽

Author(s):

C Andrew Combs ◽

◽

Thomas J Garite ◽

Kimberly Maurel ◽

Kimberly Mallory ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Early Termination ◽

Double Blind ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone

Download Full-text

17-Hydroxyprogesterone Caproate for Twin Pregnancy: A Double-Blind, Randomized Clinical Trial

Obstetrical & Gynecological Survey ◽

10.1097/ogx.0b013e31823383b7 ◽

2011 ◽

Vol 66 (7) ◽

pp. 393-394

Author(s):

C. Andrew Combs ◽

Thomas Garite ◽

Kimberly Maurel ◽

Anita Das ◽

Manuel Porto

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Twin Pregnancy ◽

Double Blind ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone

Download Full-text

17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2010.12.042 ◽

2011 ◽

Vol 204 (3) ◽

pp. 221.e1-221.e8 ◽

Author(s):

C. Andrew Combs ◽

Thomas Garite ◽

Kimberly Maurel ◽

Anita Das ◽

Manuel Porto

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Twin Pregnancy ◽

Double Blind ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone

Download Full-text

A Randomized Controlled Double-Blind Clinical Trial of 17-Hydroxyprogesterone Caproate for the Prevention of Preterm Birth in Twin Gestation (PROGESTWIN)

Obstetric Anesthesia Digest ◽

10.1097/01.aoa.0000472738.17424.a9 ◽

2015 ◽

Vol 35 (4) ◽

pp. 217 ◽

Author(s):

J. Awwad ◽

I.M. Usta ◽

G. Ghazeeri ◽

N. Yacoub ◽

J. Succar ◽

...

Keyword(s):

Clinical Trial ◽

Preterm Birth ◽

Double Blind ◽

Randomized Controlled ◽

Double Blind Clinical Trial ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone

Download Full-text

A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity

BJOG An International Journal of Obstetrics & Gynaecology ◽

10.1111/1471-0528.13031 ◽

2014 ◽

Vol 122 (1) ◽

pp. 71-79 ◽

Author(s):

J Awwad ◽

IM Usta ◽

G Ghazeeri ◽

N Yacoub ◽

J Succar ◽

...

Keyword(s):

Clinical Trial ◽

Preterm Birth ◽

Neonatal Morbidity ◽

Double Blind ◽

Double Blind Clinical Trial ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone ◽

Randomised Controlled

Download Full-text

Randomized clinical trial of the efficacy of dydrogesterone, 17-hydroxyprogesterone caproate, and micronized progesterone in prevention preterm birth and premature birth in pregnant women with a short cervix

Rossiiskii vestnik akushera-ginekologa ◽

10.17116/rosakush201717188-101 ◽

2017 ◽

Vol 17 (1) ◽

pp. 88

Author(s):

O. A. Pustotina ◽

A. A. Seliverstov

Keyword(s):

Clinical Trial ◽

Preterm Birth ◽

Pregnant Women ◽

Randomized Clinical Trial ◽

Premature Birth ◽

Short Cervix ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone ◽

Micronized Progesterone

Download Full-text

Faculty Opinions recommendation of Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5603956.793505106 ◽

2015 ◽

Author(s):

Meekai To

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Neonatal Morbidity ◽

Triplet Pregnancy ◽

Double Blind ◽

17 Hydroxyprogesterone

Download Full-text

Faculty Opinions recommendation of A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718548088.793505108 ◽

2015 ◽

Author(s):

Meekai To

Keyword(s):

Clinical Trial ◽

Preterm Birth ◽

Neonatal Morbidity ◽

Double Blind ◽

Double Blind Clinical Trial ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone ◽

Randomised Controlled

Download Full-text

Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2010.06.016 ◽

2010 ◽

Vol 203 (3) ◽

pp. 248.e1-248.e9 ◽

Author(s):

C. Andrew Combs ◽

Thomas Garite ◽

Kimberly Maurel ◽

Anita Das ◽

Manuel Porto

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Neonatal Morbidity ◽

Triplet Pregnancy ◽

Double Blind ◽

17 Hydroxyprogesterone

Download Full-text

575: 17-hydroxyprogesterone caproate for preterm rupture of membranes: a randomized, double-blind, placebo-controlled clinical trial

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2014.10.781 ◽

2015 ◽

Vol 212 (1) ◽

pp. S287

Author(s):

C Andrew Combs ◽

Thomas Garite ◽

Kimberly Maurel ◽

Diana Abril ◽

Anita Das ◽

...

Keyword(s):

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Hydroxyprogesterone Caproate ◽

17 Hydroxyprogesterone ◽

Preterm Rupture Of Membranes

Download Full-text

Faculty Opinions recommendation of Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.5603956.5571054 ◽

2010 ◽

Author(s):

Watson Bowes

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Neonatal Morbidity ◽

Triplet Pregnancy ◽

Double Blind ◽

17 Hydroxyprogesterone

Download Full-text